2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapy

MLA

Li, J., et al. 2q36.3 Is Associated with Prognosis for Oestrogen Receptor-Negative Breast Cancer Patients Treated with Chemotherapy. 2014. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1315707517&authtype=sso&custid=ns315887.

APA

Li, J., Lindstroem, L., Foo, J., Rafiq, S., Schmidt, M., Pharoah, P., Michailidou, K., Dennis, J., Bolla, M., Wang, Q., Van’t Veer, L., Cornelissen, S., Rutgers, E., Southey, M., Apicella, C., Dite, G., Hopper, J., Fasching, P., Haeberle, L., … Czene, K. (2014). 2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapy.

Chicago

Li, J, Ls Lindstroem, Jn Foo, S Rafiq, Mk Schmidt, Pdp Pharoah, K Michailidou, et al. 2014. “2q36.3 Is Associated with Prognosis for Oestrogen Receptor-Negative Breast Cancer Patients Treated with Chemotherapy.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1315707517&authtype=sso&custid=ns315887.